Pfizer Inks $17B Deal For Biosimilars Giant Hospira
Pfizer Inc. finally struck a big-ticket deal months after its blockbuster bid for AstraZeneca PLC collapsed, saying Thursday it would scoop up injectables and biosimilars giant Hospira Inc. in a deal...To view the full article, register now.
Already a subscriber? Click here to view full article